Replimune's (REPL) RP1s Likely to Get Accelerated Approval - Cantor Fitzgerald

November 12, 2025 7:43 AM EST Send to a Friend
Cantor Fitzgerald analyst Li Watsek reiterated an Overweight rating on Replimune Group (NASDAQ: REPL).The analyst commented, "We are ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login